USVP Targets $400M for Fund XIV

U.S. Venture Partners has filed to raise up to $400M for U.S. Venture Partners XIV, L.P., the Menlo Park firm's 14th venture fund. The July 31, 2026 Form D reports $0 sold, 0 investors, and a first sale that has yet to occur, so this is a fundraising target rather than a completed close.

The target matches the announced size of USVP's prior fund. In December 2022, the firm said it had closed Fund XIII at $400M for Series A and B investments across cybersecurity, enterprise software, consumer, and healthcare. That continuity makes Fund XIV less a reach for a bigger headline and more a test of whether USVP's long-running early-stage model still commands limited-partner conviction.

What Happened

U.S. Venture Partners XIV, L.P. filed a new notice of exempt offering with the U.S. Securities and Exchange Commission on July 31. The Delaware limited partnership listed a total offering amount of $400M and described itself as a venture capital fund. The filing also listed $400M remaining, no sales commissions or finders' fees, and no completed first sale.

Those details draw the bright line around the news. USVP has opened the vehicle and set the ceiling, but the filing does not establish a first close, final close, investor roster, portfolio construction plan, or deployment schedule. Venture fundraising has a habit of turning the number on the cover into assumed money in the bank. The SEC form says the bank part comes later.

The filing names Dafina Toncheva, Richard W. Lewis, Jonathan D. Root, and Casey Tansey as managing members of the general partner. Dale Holladay signed the document as CFO. USVP's current team page corroborates those identities, using Rick Lewis and Jon Root as the common display names for 2 of the managing members.

Why the $400M Target Matters

Fund size is strategy wearing a number. Too small, and a lead investor can struggle to reserve enough capital for follow-on support. Too large, and the pressure to deploy can pull a manager away from the stage, ownership discipline, and sectors that built its record. By targeting the same $400M headline size as Fund XIII, USVP is signaling continuity before it has disclosed the finer points of Fund XIV's mandate.

The comparison is useful, but it has limits. USVP's Fund XIII announcement described a strategy of leading Series A or B investments in companies based in the United States or Israel. The firm emphasized cybersecurity, enterprise software, consumer, and healthcare. Fund XIV's filing does not confirm that exact geographic or stage mandate, so the prior strategy is context, not a substitute for new terms.

For founders, a consistent fund size can be more informative than an inflated one. It suggests that the manager may be trying to preserve a familiar portfolio model instead of inventing a fresh identity every fundraising cycle. For limited partners, however, continuity still has to be earned through commitments, terms, realized performance, and a clear explanation of how the next vehicle will use its capital.

The Record Behind the Raise

USVP says it has invested in more than 500 companies across 4 decades. Its current materials identify cybersecurity, enterprise software, consumer, and healthcare as core areas, with portfolio examples that include Box, Cato Networks, Human Interest, Inari Medical, Omada Health, Pluto TV, and Yammer. These examples show the breadth of the firm's historical reach, but they should not be read as commitments for Fund XIV.

The firm's 2022 Fund XIII announcement supplied the sharper historical pitch. USVP reported 93 portfolio-company IPOs, 100 profitable acquisitions, $1.1B distributed to limited partners from 2020 through the announcement, and a 3.5x realization track record across its 4 most recent fully invested funds. Those are dated, company-reported metrics rather than Fund XIV results, but they explain the evidence USVP can put in front of prospective limited partners.

Fund XIII also offers a regulatory comparison. Its initial February 2022 filing targeted $350M, and a December 2022 amendment increased the offering to $400M while reporting about $368.7M sold at that point. USVP announced the fund as closed at $400M on December 14, 2022. Fund XIV begins with the larger target already on the form, but its path from filing to close remains unwritten.

What Fund XIV Signals

The filing arrives at a moment when venture firms face a less forgiving capital market. Limited partners can ask for more evidence, fund managers have to defend the relationship between fund size and strategy, and founders increasingly care whether a lead investor can support a company beyond the first check. A familiar target gives USVP a coherent starting point, but familiarity is not the same as inevitability.

Fund XIV's strongest signal is restraint in the number and uncertainty in everything around it. USVP is not advertising a sudden jump in scale, and the filing does not provide enough information to manufacture a grand strategic pivot. The defensible reading is narrower: a veteran early-stage firm is seeking up to $400M for its next vehicle and is asking the market to underwrite continuity.

That makes the next disclosures more important than the opening filing. Investors should watch for a first sale, a closing announcement, the vehicle's stage and sector mandate, and any detail on portfolio construction. Founders should watch whether the next fund preserves USVP's stated lead-investor posture and whether the people named in the filing remain directly involved in company building.

The Bigger Industry Shift

Venture capital spent years treating asset growth as a personality trait. The harder market has brought fund mechanics back into the conversation: how much a manager is raising, what it can responsibly deploy, where it can win, and whether realized returns support the next ask. USVP's $400M target fits that reset because it repeats the prior fund's size instead of trying to win the announcement with scale alone.

The distinction between targeted and raised capital is the first test of serious coverage. As of the July 31 filing, U.S. Venture Partners XIV had reported $0 sold. The vehicle is real, the $400M ambition is documented, and the fundraising work is just beginning. In a market full of premature certainty, that is not a small caveat. It is the story.